"Vitreous Body" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe.
Descriptor ID |
D014822
|
MeSH Number(s) |
A09.371.714.500
|
Concept/Terms |
Vitreous Body- Vitreous Body
- Bodies, Vitreous
- Body, Vitreous
- Vitreous Bodies
- Vitreous Humor
- Humor, Vitreous
- Humors, Vitreous
- Vitreous Humors
|
Below are MeSH descriptors whose meaning is more general than "Vitreous Body".
Below are MeSH descriptors whose meaning is more specific than "Vitreous Body".
This graph shows the total number of publications written about "Vitreous Body" by people in this website by year, and whether "Vitreous Body" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 1 | 1 |
2003 | 2 | 0 | 2 |
2004 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vitreous Body" by people in Profiles.
-
Goldsmith ZK, Coppess W, Irvine AS, Yuan K, Barsh SR, Ritter MK, McEwen MW, Flores-Otero J, Garcia-Vargas A, Martinez-Ferrer M, Brennan RC, Morales-Tirado VM, Wilson MW. Targeting the Platelet-Derived Growth Factor-beta Stimulatory Circuitry to Control Retinoblastoma Seeds. Invest Ophthalmol Vis Sci. 2018 09 04; 59(11):4486-4495.
-
Maturi RK, Bleau L, Saunders J, Mubasher M, Stewart MW. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY. Retina. 2015 Aug; 35(8):1604-14.
-
Cheung LK, Eaton A. Age-related macular degeneration. Pharmacotherapy. 2013 Aug; 33(8):838-55.
-
Sengupta N, Afzal A, Caballero S, Chang KH, Shaw LC, Pang JJ, Bond VC, Bhutto I, Baba T, Lutty GA, Grant MB. Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization. Invest Ophthalmol Vis Sci. 2010 May; 51(5):2697-704.
-
Sardar DK, Swanland GY, Yow RM, Thomas RJ, Tsin AT. Optical properties of ocular tissues in the near infrared region. Lasers Med Sci. 2007 Mar; 22(1):46-52.
-
Kurtz D, Manny R, Hussein M. Variability of the ocular component measurements in children using A-scan ultrasonography. Optom Vis Sci. 2004 Jan; 81(1):35-43.
-
LeDay AM, Ganguly S, Kulkarni KH, Dash A, Opere CA, Ohia SE. Effect of hydrogen peroxide on amino acid concentrations in bovine retina and vitreous humor, ex vivo. Methods Find Exp Clin Pharmacol. 2003 Nov; 25(9):695-701.
-
Katz A, Kruger EF, Minko G, Liu CH, Rosen RB, Alfano RR. Detection of glutamate in the eye by Raman spectroscopy. J Biomed Opt. 2003 Apr; 8(2):167-72.
-
Skatchkov SN, Krusek J, Reichenbach A, Orkand RK. Potassium buffering by M?ller cells isolated from the center and periphery of the frog retina. Glia. 1999 Aug; 27(2):171-80.
-
Alpar JJ. The role of 1% sodium hyaluronate in treating vitreous incarceration with the neodymium:YAG laser in patients with corneal decompensation. J Cataract Refract Surg. 1986 Sep; 12(5):502-6.